Catalyst Wire Dossier Catalyst Wire Dossier

Bonviva (ibandronate)

ibandronate · Hoffmann-La Roche
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bonviva (ibandronate), covering 2016-11-02 to 2016-11-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Ibandronate (Bonviva) in Patients With Post-Menopausal Osteoporosis [Phase 4]

See pricing